ArticleProceedings of the National Academy of Sciences of the United States of America2012

Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.

Ronald E Cannon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.